SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3974Here's a weird bio ipo: Reuters UPDATE - New River sets IPO at 4.2 mln sharkrw7/16/2004
3973I'm glad I can contribute something useful to this thread (and the SI biotecsjemmeri7/16/2004
3972Thanks for finding that. I wasn't aware XGEN was trying again. They missedtuck7/16/2004
3971please keep that sort of commentary coming. thanks. Rickscaram(o)uche7/16/2004
3970Weak IPO pricing for 'tools' co.: 10:58 ET Xenogen IPO prices below ransjemmeri7/16/2004
3969Soft Market Spurs Venture Firms To Buy Biotech IPO Shares By TOM SALEMI July 13mopgcw7/13/2004
3968It is exceedingly easy to get excited about company press releases, rather than Mike McFarland7/11/2004
3967>> Sleazy dealings << The markets should be "fair". I prscaram(o)uche7/8/2004
3966I've always looked at them as complicit agreements. Short our stock, make morkrw7/8/2004
3965>>gives us traders good entries, as well as frustration.>> And makeIcebrg7/8/2004
3964and yet they'll let forward-sales agreements play out in the public market? scaram(o)uche7/8/2004
3963From the WSJ on Avastin: Speculating about Avastin's prospects is one of thDoc Bones7/8/2004
3962'Pipe' Stock Deals Are Reviewed SEC Probes Hedge Funds, Brokers On How Doc Bones7/8/2004
3961I didn't see his estimate..... high or low?? Low, I presume. <i>Oscaram(o)uche7/7/2004
3960<<Avastin(TM) (bevacizumab), in its first full quarter of sales, realized rkrw7/7/2004
3959<i>Avastin(TM) (bevacizumab), in its first full quarter of sales, realizedscaram(o)uche7/7/2004
3958Biotech Raises Nearly $15 Billion in First Half of 2004 Wednesday July 7, 2:01 pscaram(o)uche7/7/2004
3957Looney Brothers is out this morning, cutting the biotech sector to neutral. If scaram(o)uche6/28/2004
3956I saw that this morning. I still can't believe how long they held...Must lomopgcw6/25/2004
3955chuckle. yeah, I remember when they were buying. they stuck it out, all this tscaram(o)uche6/25/2004
3954BVF AVM holding up 30% today due to pr regarding potential approval of Combidex Extra Pale6/25/2004
3953and thanks for sharing the capsule view. (eom)scaram(o)uche6/23/2004
3952>> sort of like the difficulty in exactly copying conjugated estrogens <scaram(o)uche6/23/2004
3951Looking over the Momenta S1, some interesting private rounds: HUGE step up frorkrw6/23/2004
3950a little late to the party....Guilford Pharmaceuticals Inc. Announces Proposed Omopgcw6/21/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):